GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update Life Science Investing
Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates Life Science Investing
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 Psychedelics Investing
Medtronic announces expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 Catheter for treatment of ventricular arrhythmias Medical Device Investing
Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update Life Science Investing
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin Psychedelics Investing
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 Life Science Investing
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
